Eye injection trial aims to slow vision loss in inherited blindness

NCT ID NCT06627179

Recruiting now Disease control Sponsor: Laboratoires Thea Source: ClinicalTrials.gov ↗

Summary

This study is testing an experimental drug called ultevursen, given as an injection into the eye, for people with a specific genetic type of retinitis pigmentosa (RP). The goal is to see if it can slow down the loss of vision over two years. About 81 participants will be randomly assigned to receive either the real injection or a sham (pretend) procedure.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

AOU Università degli Studi della Campania Luigi Vanvitelli
NOT_YET_RECRUITING

Naples, 80131, Italy
ASST Santi Paolo e Carlo Hospital, University of Milan
RECRUITING

Milan, 20142, Italy
Amsterdam University Medical Center - Locatie AMC
RECRUITING

Amsterdam, 1105 AZ, Netherlands
Bascom Palmer Eye Institute/University of Miami
RECRUITING

Miami, Florida, 33136, United States
Baylor College of Medicine
RECRUITING

Houston, Texas, 77030, United States
Casey Eye Institute, Oregon Health & Science University
RECRUITING

Portland, Oregon, 97239, United States
Centre de maladies rares CHNO des Quinze Vingt
RECRUITING

Paris, 75012, France
Duke Eye Center
RECRUITING

Durham, North Carolina, 27705, United States
Emory University
RECRUITING

Atlanta, Georgia, 30322, United States
Federal University of São Paulo - Hospital São Paulo (UNIFESP-HSP)
RECRUITING

São Paulo, 04021-001, Brazil
Ghent University Hospital
RECRUITING

Ghent, B-9000, Belgium
Het Oogziekenhuis Rotterdam
RECRUITING

Rotterdam, 3011 BH, Netherlands
Hospital for Sick Children
RECRUITING

Toronto, Ontario, M5G1E8, Canada
Hôpital Gui de Chauliac - CHRU de Montpellier - Maladies Sensorielles Génétique
RECRUITING

Montpellier, 34295, France
Massachusetts Eye and Ear
RECRUITING

Boston, Massachusetts, 02114, United States
McGill University Health Centre for Innovative Medicine
RECRUITING

Montreal, Quebec, H4A3J1, Canada
Moorfields Eye Hosptial
RECRUITING

London, EC1V 2PD, United Kingdom
Oxford Eye Hospital
RECRUITING

Headington, Oxford, OX3 9DU, United Kingdom
Radboud Universitair Medisch Centrum
RECRUITING

Nijmegen, 6525 GA, Netherlands
Retina Foundation of the Southwest
RECRUITING

Dallas, Texas, 75231, United States
Rigshospitalet and University of Copenhagen
RECRUITING

Glostrup Municipality, 2600, Denmark
The University of California, San Francisco
RECRUITING

San Francisco, California, 94143, United States
University of Edinburgh / NHS Lothian
RECRUITING

Edinburgh, EH39HA, United Kingdom
University of Michigan- Kellogg Eye Center
RECRUITING

Ann Arbor, Michigan, 48105, United States
University of Pennsylvania, Scheie Eye Institute
RECRUITING

Philadelphia, Pennsylvania, 19104, United States
University of Wisconsin- Madison
RECRUITING

Madison, Wisconsin, 53705, United States
Universitätsklinikum Tübingen
RECRUITING

Tübingen, 72076, Germany

Conditions

Explore the condition pages connected to this study.

DEAF BLIND EYE DISEASES, HEREDITARY EYE DISORDERS CONGENITAL RETINAL DISEASE RETINITIS PIGMENTOSA (RP) USHER SYNDROME TYPE 2 VISION DISORDERS